CTI BIOPHARMA CORP Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Cti Biopharma Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2022.
  • Cti Biopharma Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $9.63M, a 84.3% decline year-over-year.
  • Cti Biopharma Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $120M, a 22.5% increase from 2021.
  • Cti Biopharma Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was $97.9M, a 60.4% increase from 2020.
  • Cti Biopharma Corp annual Net Cash Provided by (Used in) Financing Activities for 2020 was $61.1M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $120M +$22.1M +22.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-06
2021 $97.9M +$36.9M +60.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 $61.1M +$66.7M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$5.61M -$69.1M -109% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 $63.5M +$24.5M +62.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $39M +$46.3M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 -$7.37M -$159M -105% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 $152M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2013 $59M -$28.2M -32.4% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-04
2012 $87.2M +$212K +0.24% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-04
2011 $87M +$37.3M +75% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-04
2010 $49.7M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.